Teva said to pay $250 million to end Nevada colonoscopy hepatitis cases
By Bloomberg
Posted: February 21, 2012 - 7:30 pm ET
Tags:
Teva Pharmaceutical Industries will pay more than $250 million to settle more than 80 lawsuits alleging the drugmaker sold the anesthetic Propofol in a way that led some patients to develop hepatitis C, people familiar with the accords said.